The transcriptional coactivator WBP2 primes triple-negative breast cancer cells for responses to Wnt signaling via the JNK/Jun kinase pathway

This publication has 84 references indexed in Scilit:

• PAWS1 controls Wnt signalling through association with casein kinase 1α
  EMBO Reports, 2018
• WBP2 modulates G1/S transition in ER+ breast cancer cells and is a direct target of miR-206
  Cancer Chemotherapy and Pharmacology, 2017
• A genome-wide screen identifies YAP/WBP2 interplay conferring growth advantage on human epidermal stem cells
  Nature Communications, 2017
• Gene expression microarray data from human microvascular endothelial cells supplemented with a low concentration of niacin
  Data in Brief, 2016
• Transcriptome Analysis of Wnt3a-Treated Triple-Negative Breast Cancer Cells
  PLOS ONE, 2015
• SOX4 Induces Epithelial–Mesenchymal Transition and Contributes to Breast Cancer Progression
  Cancer Research, 2012
• Activation of non-canonical Wnt/JNK pathway by Wnt3a is associated with differentiation fate determination of human bone marrow stromal (mesenchymal) stem cells
  Biochemical and Biophysical Research Communications, 2011
• The enormous influence of TNIK knockdown on intracellular signals and cell survival
  Human Cell, 2011
• WBP-2, a WW domain binding protein, interacts with the thyroid-specific transcription factor Pax8
  Biochemical Journal, 2004
• Axin Forms a Complex with MEKK1 and Activates c-Jun NH2-terminal Kinase/Stress-activated Protein Kinase through Domains Distinct from Wnt Signaling
  Journal of Biological Chemistry, 1999